AI-generated summary
The authors compared 1,064-nm Nd:YAG laser treatment plus topical imiquimod 5% cream with laser plus placebo cream for tattoo removal in a small, double-blinded trial. They report that the imiquimod group had higher clearance scores from investigators (4.3 versus 2.7) and subjects (4.7 versus 2.3), with only mild itching and no scarring. The trial enrolled just three patients, so the authors call for larger studies.
- Participants
- 3
- Who or what was studied
- Three patients with Fitzpatrick skin type IV, aged 18-65, with dark blue or black tattoos
- Limits stated in the abstract
- The trial enrolled only three patients, so the authors state that larger studies are needed.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Total energy
- 4 J
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Placebo-controlled. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.